Literature DB >> 15954929

Different responses by cultured aortic and venous smooth muscle cells to gamma radiation.

Seung-Jung Kim1, Takahisa Masaki, Roy Rowley, John K Leypoldt, Syed F Mohammad, Alfred K Cheung.   

Abstract

BACKGROUND: Stenosis of hemodialysis arteriovenous grafts is usually focal and caused by the proliferation of vascular smooth muscle cells (SMCs). External radiation of the graft is a potential strategy to prevent stenosis; however, the relative responsiveness of arterial and venous SMCs to radiation is unknown.
METHODS: Human aortic and saphenous vein SMCs were cultured in a medium containing growth factors and serum and treated with 0 to 50 Gy in a gamma irradiator. At 2 to 20 days post-irradiation, cell counting, methylthiazoletetrazolium dye reduction, [(3)H]-thymidine uptake, and bromodeoxyuridine (BrdU) incorporation assays were performed.
RESULTS: All assays showed that 1 to 50 Gy inhibited the proliferation of both aortic and venous SMCs in a dose-dependent manner. Importantly, venous cells were less susceptible to radiation in all assays, compared to aortic cells. At day 10, 1 to 50 Gy of radiation inhibited the increase in the number of aortic cells by 24% to 66% and venous cells by 8% to 25% (P < 0.01) (aortic vs. venous). The differences between aortic and venous cells varied among different assays and were most pronounced in the BrdU assay.
CONCLUSION: Inasmuch as myointimal hyperplasia occurs at both arterial and venous anastomoses, future strategies using radiation to prevent hemodialysis vascular access stenosis should take these differences into consideration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15954929     DOI: 10.1111/j.1523-1755.2005.00407.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  3 in total

Review 1.  "Venopathy" at work: recasting neointimal hyperplasia in a new light.

Authors:  Alexander S Yevzlin; Micah R Chan; Yolanda T Becker; Prabir Roy-Chaudhury; Timmy Lee; Bryan N Becker
Journal:  Transl Res       Date:  2010-08-13       Impact factor: 7.012

2.  In-vitro Release of Rapamycin from a Thermosensitive Polymer for the Inhibition of Vascular Smooth Muscle Cell Proliferation.

Authors:  Weiwei Zhu; Takahisa Masaki; Alfred K Cheung; Steven E Kern
Journal:  J Bioequivalence Bioavailab       Date:  2009-05-09

3.  Pathogenesis and local drug delivery for prevention of vascular access stenosis.

Authors:  Alfred K Cheung; Christi Terry; Li Li
Journal:  J Ren Nutr       Date:  2008-01       Impact factor: 3.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.